1.Clinical analysis of 25 cases of autologous urological neoplasms in renal transplant recipients
Qing YANG ; Chengwu XIAO ; Linhui WANG ; Bing LIU ; Rui LUO ; Peng WAN ; Xin CHENG ; Yinhao SUN
Chinese Journal of Organ Transplantation 2012;33(7):397-399
Objective To summarize the clinical features,diagnosis and treatment of autologous urologic neoplasms in renal transplant recipients.Methods A retrospective analysis on the clinical data of 25 renal transplant recipients was done in our center.The onset time of new neoplasms was between 29 to 72 months after transplantation,with an average of 48.2 months.Intermittent hematuria was the first symptom in 23 patients,and the rest two cases were diagnosed through routine examination. The pathological diagnoses of thee cases were renal carcinoma,which were treated by transperitoneal laparoscopic radical nephrectomy.Eight cases were diagnosed as having renal pelvic tumor,which was treated by radical resection for the renal pelvic carcinoma.Fourteen cases were diagnosed as having bladder cancer,which was treated by transurethral resection of bladder tumor (13 cases) or radical cystectomy (one case).All patients were subjected to surgical treatment.The dosage of MMF,CSA/Tacrolimus was decreased to 1/2-2/3 of their original dosage. Sirolimus was used in place of calcineurin inhibitors in four patients.Immunosuppressive regimes and adjuvant therapy were given after surgery treatment.Results Twenty-five patients were followed up for 12-84 months.Contralateral renal carcinoma combined with lung and chest multiple metastases occurred in one case after radical nephrectomy,who died after targeted therapy 6 months later.Two patients with lymph node metastasis died 14 months and 20 months after surgery respectively.The rest 22 patients were closely followed up,whose creatinine remained 98-163μmol/L.Conclusion More attention should be paid to patients with hematuria after renal transplantation to screen the autologous urinary neoplasms.Patients should be treated with surgical procedures,and immunosuppressive regimens should be adjusted postoperatively.
2.Surgical outcomes of robot-assisted partial nephrectomy in 12 cases
Linhui WANG ; Huamao YE ; Bin XU ; Bing LIU ; Jiatao JI ; Liang XIAO ; Xia SHENG ; Lili WANG ; Xin CHENG ; Jiong HOU ; Jianguo HOU ; Yinghao SUN
Chinese Journal of Urology 2012;(11):814-817
Objective To summarize the surgical experience in robotic-assisted laparoscopic partial nephrectomy,and to investigate the efficacy and safety of this surgery.Methods The clinical data of 12 patients who underwent robot-assisted laparoscopic partial nephrectomy in Changhai Hospital from March to July in 2012 were analyzed.All the patients were male and the age range was 43-66 years.In 4 cases the tumors were in the left kidney,and 8 in the right.In 7 cases the tumors were in the dorsal part of the kidney,and 2 in the ventral part.There were 3,5 and 4 cases in the upper,middle and lower pole of the kidney respectively.Preoperative GFR test was normal in all cases.Kidney CT scan showed the maximum diameters of the tumors were 2.0-5.8 cm,with an average of 3.3 cm.The pre-operative stages in all cases were T1N0M0.Results The surgery was successfully completed in all cases.The mean duration of the surgery was 160-310 min,with an average of 242 min.The blood loss was 30-300 ml,with an average of 135 ml,and the intraoperative blood transfusion was unnecessary.The warm ischemia time was 20-49 min,with an average of 31 min.There was no intraoperative morbidity,and no conversion to open surgery.The postoperative length of hospitalization was 9-31 d,with an average of 14 d.Gross hematuria arose in 1 patient at 1 week after the surgery.The post-operative pathology showed renal clear cell carcinoma with Furhman Grade Ⅱ in 11 cases,and renal angiomyolipoma in 1 case.The maximum diameters of the tumors were 2.0-5.0 cm,with an average of 3.5 cm.The tumor resection margin was negative in all cases.Conclusions Robot-assisted laparoscopic partial nephrectomy is safe and effective for local renal tumors.This surgery has significant advantage over traditional laparoscopic partial nephrectomy,in terms of the resection of the renal tumors and the reconstruction of the kidney.
3.Application of evidence - based perioperative nursing in transradial interventional treatment by using sheathless guiding - catheter for coronary artery lesions
Hong YE ; Shiguang LI ; Ling XIN ; Chengling AN ; Linhui CHENG
Journal of Interventional Radiology 2018;27(3):281-284
Objective To investigate the application of evidence - based perioperative nursing in transradial interventional treatment by using sheathless guiding-catheter for coronary artery lesions. Methods The evidence-based nursing team researched for the relevant literature and evidences. According to the theory of critical evidence - based nursing, evidence - based perioperative nursing measures were carried out for 30 patients with coronary artery diseases who were receiving transradial interventional treatment by using sheathless guiding-catheter. Results The success rate of puncturing was 100%. After the procedure only two patients developed radial artery complications, and after promptly treatment no severe consequences occurred. The treatment achieved the desired clinical results. Conclusion Evidence-based nursing measures can regulate nursing behavior, and presciently make the nursing work in a standardized and sequenced way, thus, the nursing work is changed from the passive mode to an active mode. Therefore, evidence - based perioperative nursing is worth of clinical application(J Intervent Radiol, 2018, 27:281 -284)
4.Yiqi Wenyang Huwei Decoction Regulates PI3K/Akt/mTOR Pathway to Treat Bronchial Asthma in Rats
Shuangdi XIANG ; Linhui CHENG ; Qiangqiang YU ; Hanrong XUE
Chinese Journal of Experimental Traditional Medical Formulae 2023;29(14):38-46
ObjectiveTo observe the regulatory effects of Yiqi Wenyang Huwei decoction (YWHD) on autophagy and phosphatidylinositol 3-kinase (PI3K)/protein kinase B(Akt)/mammalian target of rapamycin (mTOR) signaling pathway in asthmatic rats and bronchial epithelial cells (16HBE) and further reveal the mechanism of YWHD in treating bronchial asthma (BA). MethodForty-eight rats were randomly assigned into normal group, model group, dexamethasone group, and low-, medium-, and high-dose YWHD groups, with 8 rats in each group. The rat model of BA was established by intraperitoneal injection with ovalbumin (OVA) + aluminum hydroxide suspension and atomizing inhalation with OVA for 2 weeks. The normal group was administrated with an equal dose of normal saline. The bronchial maximum airway resistance (Max Rrs) induced by methacholine chloride (Mch) was determined by an animal lung function evaluation system. Enzyme-linked immunosorbent assay (ELISA) was employed to measure the levels of interleukin (IL)-4, IL-13, IL-6, IL-33, IL-25, tumor necrosis factor-α (TNF-α), and immunoglobulin E (IgE) in the bronchial alveolar lavage fluid. Hematoxylin-eosin (HE) and Masson staining were used for observation of the pathological changes of bronchi in the lung tissue. The immunofluorescence assay was employed to measure the levels of the autophagy-associated proteins LC3B and Beclin1. The IL-13-induced autophagy of 16HBE cells exposed to the YWHD-containing serum was observed, and the autophagy level was traced by mRFP-GFP-LC3 adenovirus infection. The protein levels of LC3Ⅱ/Ⅰ, p-PI3K, p-Akt and p-mTOR were determined by Western blot. ResultCompared with the normal group, the model group showed increased Max Rrs (P<0.01) and elevated levels of IL-4, IL-13, IL-6, IL-33, IL-25, TNF-α, and IgE in the bronchial alveolar lavage fluid (P<0.05,P<0.01). The modeling caused focal infiltration of inflammatory cells and lymphocytes around bronchus and blood vessels, epithelial goblet cell metaplasia, and increased subepithelial collagen deposition. Furthermore, it up-regulated the protein levels of LC3B and Beclin1 (P<0.01), promoted the autophagy flux of GFP to mRFP in 16HBE cells induced by IL-13, down-regulated the protein levels of p-PI3K, p-Akt, and p-mTOR, and increased the LC3Ⅱ/Ⅰ ratio (P<0.01). Compared with the model group, medium- and high-dose YWHD decreased Max Rrs (P<0.01), lowered the levels of IL-4, IL-13, IL-6, IL-33, IL-25, TNF-α, and IgE in the bronchial alveolar lavage fluid (P<0.05, P<0.01), and reduced lymphocyte and granulocyte infiltration in bronchi of the lung tissue, epithelial goblet cell metaplasia, and subepithelial collagen deposition. Moreover, they down-regulated the protein levels of LC3B and Beclin1 (P<0.05, P<0.01), decreased the autophagy flux of GFP to mRFP, up-regulated the protein levels of p-PI3K, p-Ak, and p-mTOR, and decreased the LC3Ⅱ/Ⅰ ratio (P<0.05, P<0.01). ConclusionYWHD ameliorates airway hyperresponsiveness and airway inflammation and inhibits the autophagy of airway epithelial cells in the lung tissue of BA rats by activating the PI3K/Akt/mTOR signaling pathway.
5.Cryoablation of renal cell carcinoma: six-year experience with 64 cases
Bin XU ; Shangqing SONG ; Zhenjie WU ; Bing LIU ; Qing YANG ; Liang XIAO ; Yajun CHENG ; Guopeng YU ; Long LI ; Zhong WANG ; Linhui WANG ; Yinghao SUN
Chinese Journal of Urology 2018;39(6):422-427
Objective To summarize our clinical experience of cryoablation for renal cancer and to analyze the therapeutic indication,security,selection of cryoablation and outcomes.Methods Sixty-four patients suffered with T1a renal cell carcinoma were enrolled in this study from March 2012 to March 2018.Among them,5 cases were senile patients (≥ 80 years),5 cases complicated with other cancers,3 cases complicated with renal insufficiency,4 cases complicated with decompensated cirrhosis,3 cases with bilateral renal cancer,4 cases with solitary kidney cancer and 39 cases with some other complications.The preoperative serum creatinine level was(80.5 ± 38.2)μmol/L.The patients underwent laparoscopic singlesite (LESS) renal cryoablation,conventional laparoscopic renal cryoablation,or percutaneous image-guided cryoablation according to individual situation.Contrast-enhanced CT scan or MRI were used during the procedures and follow-up was performed.Results All operations were completed successfully and technical success was achieved as well in all cases.Blood transfusion was necessary for 2 cases because of hemorrhage.The mean diameter of the mass was (2.6 ± 0.90) cm,the median volume of blood loss was 50ml(10-110 ml),and the mean operation time was(96.0 ± 24.5) min.The median inpatient hospital stay was 3 d (1-6 d).In one case,digital subtraction angiography (DSA) embolization was performed due to hemorrhage after surgery.None of the other cases had intraoperative or postoperative complications.The serum creatinine level after surgery was not significantly decreased [postoperative (83.8 ±42.1) μmol/L,P =0.64].The contrast-enhanced CT or MRI of the kidneys one week postoperatively showed uniform low density in all lesion areas,which represented complete ablation and regression of the tumor.All cases were followed up regularly.One case showed relapse at the 6 th month follow-up and underwent cryoablation again.Another case,who was not regularly followed up,relapsed at 69th month after surgery.No relapse was observed in the other cases during the follow-up.Conclusions Renal cancer cryoablation is a safe,feasible and efficacious therapy for the patients who suffered from unresectable T1a renal cell carcinoma because of high surgical risk or multifocal lesions.
6.Value of different assessment scales in the diagnosis of drug-induced liver injury
Jiaxi MA ; Tiantian YAO ; Hao CHENG ; Dan LIU ; Yuhan ZHANG ; Siyuan DU ; Linfei DONG ; Linhui HU ; Yan WANG ; Guiqiang WANG
Journal of Clinical Hepatology 2024;40(6):1203-1208
ObjectiveTo determine the scores of patients with a confirmed diagnosis of drug-induced liver injury (DILI) using Roussel Uclaf Causality Assessment Method (RUCAM), Maria & Victorino assessment scale, and Revised Electronic Causality Assessment Method (RECAM), to compare the accuracy of the three scales in diagnosis, and to investigate their clinical significance in the diagnosis of DILI. MethodsA total of 98 patients with a confirmed diagnosis of DILI who were hospitalized in Peking University First Hospital from January 2011 to December 2022 were enrolled, with liver biopsy results supporting DILI and a clear history of medication. Clinical data were collected from all subjects, and the above causality assessment scales were used for scoring. The chi-square test was used to analyze the diagnostic accuracy of the causality assessment scales, and the weighted kappa coefficient was used to analyze the consistency between the three scales. ResultsFor all patients with DILI enrolled, RECAM had the highest accuracy, with a significant difference compared with RUCAM (χ2=5.667,P=0.017). RUCAM and RECAM had moderate consistency in diagnosis (κw=0.469), while RECAM and Maria & Victorino scale had poor consistency (κw=0.156). For the patients with acute DILI, RECAM, RUCAM, and Maria & Victorino scales had a diagnostic inconsistency rate of 3.7%, 11.1%, and 42.6%, respectively; for the patients with hepatocellular type DILI, the three scales of a diagnostic inconsistency rate of 8.9%, 21.4%, and 62.5%, respectively; for the patients with cholestasis type or mixed type DILI, the three scales of a diagnostic inconsistency rate of 10.0%, 22.5%, and 47.5%, respectively. ConclusionThe use of RECAM and RUCAM scales in acute DILI can improve diagnostic rate, and for hepatocellular type DILI and DILI with the clinical manifestation of cholestasis (cholestasis type DILI and mixed type DILI), the use of RECAM and RUCAM scales can also improve diagnostic rate. The selection of causality assessment scales with a relatively high accuracy based on the course and clinical classification of the disease may help to further improve clinical diagnostic rate.